General contact

Main switchboard

+41 61 324 11 11
+41 61 324 80 01
Monday - Friday,
8:30 a.m. - 5:00 p.m. GMT+1

US switchboard

+1 862 778 21 00
Monday - Friday,
8:30 a.m. - 5:00 p.m. EST


Global Media Relations
Eric Althoff
Basel, Switzerland

+41 61 324 7999


Investor Relations

Monday - Friday,
8:30 a.m. - 5:30 p.m. GMT+1
(Central European Time)

Reporting side effects

Report a suspected side effect (also known as an adverse event) related to a Novartis Pharmaceutical drug or a Novartis Vaccine.

Reporting side effects

pane 4 content

Responsible business practices

At Novartis, we pursue high performance with high integrity. It is our conviction that responsible business results in better business.

We are committed to being a leader in corporate responsibility, and were one of the first signatories to the United Nations Global Compact, the world's largest corporate citizenship initiative. The Global Compact calls on business and other stakeholders to support key principles in the areas of human rights, labor, environment and anti-corruption. These standards are embedded throughout our operations, and we strive for continuous improvement by measuring, monitoring and reporting on our progress.